CD4 and acute myeloid leukemia: In the current study, by performing multivariate analysis including baseline characteristics and ELN-defined genetic risk category, we found that a lower proportion of CD4 Tem at diagnosis independently predicted poorer RFS in AML, which coincided with superior anti-tumor capacity of memory cells.